Product Information
LEVO-T 137 MCG TABLET is a generic product labeled by Neolpharma, Inc., priced at $0.0630 per EA under NDC 55466011111. Its NADAC has been published 517 times since Aug 3, 2016.
Strength
137 ug/1
Manufacturer
Neolpharma, Inc.NDC
55466011111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021342On Market Since
10/29/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVO-T 137 MCG TABLET has been published 517 times since Aug 3, 2016, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0630 per EA |
|---|---|
| All-time high | $0.4976 (Oct 12, 2016) |
| All-time low | $0.0555 (Jul 17, 2024) |
| 52-week high | $0.0767 |
| 52-week low | $0.0630 |
| Median price | $0.3060 |
| Average price | $0.2693 |
| Largest weekly change | +51.0% (Jun 19, 2024) |
| Weeks tracked | 517 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVO-T 137 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVO-T 137 MCG TABLET, manufactured by Neolpharma, Inc., is $0.0630 per EA (NDC 55466011111), effective Jun 24, 2026.
How has the price of LEVO-T 137 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVO-T 137 MCG TABLET has declined 86.3%. It has been tracked across 517 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for LEVO-T 137 MCG TABLET?
Since Aug 3, 2016, the NADAC for LEVO-T 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.4976 (Oct 12, 2016), with a median of $0.3060 per EA.
Are there cheaper alternatives to LEVO-T 137 MCG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEVO-T 137 MCG TABLET, but none are currently priced below it.
Who manufactures LEVO-T 137 MCG TABLET?
LEVO-T 137 MCG TABLET (NDC 55466011111) is labeled by Neolpharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification